Harmony Biosciences Holdings, Inc. HRMY Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $752.5M+66.1% | $453M+45.4% | $311.66M+27.8% | $243.78M+4.0% | ||
| $22.84M+61.0% | $14.19M-66.1% | $41.8M-47.3% | $79.33M— | ||
| $396.39M+21.1% | $327.41M+27.0% | $257.79M+30.4% | $197.76M+61.0% | ||
| $5.36M-25.6% | $7.2M+34.2% | $5.36M+24.8% | $4.3M-3.0% | ||
| $907.01M+56.6% | $579.25M+28.4% | $451.07M+12.7% | $400.29M+40.7% | ||
| $89.42M-21.1% | $113.26M-17.4% | $137.11M-14.8% | $160.95M+11.8% | ||
| $364.62M-13.2% | $419.95M+16.5% | $360.38M+31.7% | $273.59M+83.6% | ||
| $1.27B+27.3% | $999.2M+23.1% | $811.45M+20.4% | $673.87M+55.5% | ||
| $17.69M+28.7% | $13.74M-22.5% | $17.73M+368% | $3.79M+278% | ||
| $20M+23.1% | $16.25M+8.3% | $15M+650% | $2M0.0% | ||
| $252.13M+44.0% | $175.08M+6.9% | $163.78M+108% | $78.88M+46.7% | ||
| $143.66M-11.9% | $163.02M-8.7% | $178.57M-5.8% | $189.65M-0.2% | ||
| $149.28M-9.5% | $164.96M-8.7% | $180.68M-6.0% | $192.15M-0.5% | ||
| $401.41M+18.0% | $340.05M-1.3% | $344.46M+27.1% | $271.03M+9.8% | ||
| $1K0.0% | $1K0.0% | $1K0.0% | $1K0.0% | ||
| $160.9M+7,161% | $2.22M+102% | -$143.28M+47.3% | -$272.13M+40.0% | ||
| $870.22M+32.0% | $659.16M+41.1% | $466.99M+15.9% | $402.84M+116% | ||
| $1.27B+27.3% | $999.2M+23.1% | $811.45M+20.4% | $673.87M+55.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Harmony Biosciences Holdings, Inc. cover its short-term obligations?
- Its current ratio is 3.58 — current assets exceed current liabilities.
- Where does Harmony Biosciences Holdings, Inc.'s balance sheet data come from?
- Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.